Several other research analysts have also issued reports on GWLIF. Scotiabank reduced their target price on shares of Great-West Lifeco from C$37.00 to C$34.00 in a research note on Friday, November 4th. Credit Suisse Group assumed coverage on shares of Great-West Lifeco in a report on Thursday, January 12th. They issued a “neutral” rating on the stock. Royal Bank of Canada lowered their price objective on shares of Great-West Lifeco from C$42.00 to C$36.00 in a report on Friday, November 4th. BMO Capital Markets lowered their price objective on shares of Great-West Lifeco from C$33.00 to C$32.00 in a report on Friday, November 4th. Finally, Barclays lowered their price objective on shares of Great-West Lifeco from C$37.00 to C$32.00 in a report on Wednesday, October 12th.
Great-West Lifeco Trading Up 0.4 %
Shares of Great-West Lifeco stock traded up $0.11 during mid-day trading on Wednesday, reaching $25.67. 1,000 shares of the stock were exchanged, compared to its average volume of 1,792. The firm has a 50-day simple moving average of $23.61 and a 200 day simple moving average of $23.47. Great-West Lifeco has a fifty-two week low of $19.97 and a fifty-two week high of $32.70.
Great-West Lifeco Company Profile
Great-West Lifeco Inc, a financial services holding company, engages in the life and health insurance, retirement and investment services, asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers a portfolio of financial and benefit plan solutions for individuals, families, businesses, and organizations; life, disability, critical illness, accidental death, dismemberment, health and dental protection, and creditor insurance products; and retirement savings and income, annuity, and other specialty products.
- Get a free copy of the StockNews.com research report on Great-West Lifeco (GWLIF)
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Receive News & Ratings for Great-West Lifeco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Great-West Lifeco and related companies with MarketBeat.com's FREE daily email newsletter.